2024-04-012025-03-312025-03-31false02113867BRECKNOCK DENTAL SURGERY LIMITED2025-11-1986230falseiso4217:GBPxbrli:pure021138672024-03-31021138672025-03-31021138672024-04-012025-03-31021138672023-03-31021138672024-03-31021138672023-04-012024-03-3102113867bus:SmallEntities2024-04-012025-03-3102113867bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3102113867bus:FullAccounts2024-04-012025-03-3102113867bus:PrivateLimitedCompanyLtd2024-04-012025-03-3102113867core:WithinOneYear2025-03-3102113867core:AfterOneYear2025-03-3102113867core:WithinOneYear2024-03-3102113867core:AfterOneYear2024-03-3102113867core:ShareCapital2025-03-3102113867core:SharePremium2025-03-3102113867core:RevaluationReserve2025-03-3102113867core:OtherReservesSubtotal2025-03-3102113867core:RetainedEarningsAccumulatedLosses2025-03-3102113867core:ShareCapital2024-03-3102113867core:SharePremium2024-03-3102113867core:RevaluationReserve2024-03-3102113867core:OtherReservesSubtotal2024-03-3102113867core:RetainedEarningsAccumulatedLosses2024-03-3102113867core:LandBuildings2025-03-3102113867core:PlantMachinery2025-03-3102113867core:Vehicles2025-03-3102113867core:FurnitureFittings2025-03-3102113867core:OfficeEquipment2025-03-3102113867core:NetGoodwill2025-03-3102113867core:IntangibleAssetsOtherThanGoodwill2025-03-3102113867core:ListedExchangeTraded2025-03-3102113867core:UnlistedNon-exchangeTraded2025-03-3102113867core:LandBuildings2024-03-3102113867core:PlantMachinery2024-03-3102113867core:Vehicles2024-03-3102113867core:FurnitureFittings2024-03-3102113867core:OfficeEquipment2024-03-3102113867core:NetGoodwill2024-03-3102113867core:IntangibleAssetsOtherThanGoodwill2024-03-3102113867core:ListedExchangeTraded2024-03-3102113867core:UnlistedNon-exchangeTraded2024-03-3102113867core:LandBuildings2024-04-012025-03-3102113867core:PlantMachinery2024-04-012025-03-3102113867core:Vehicles2024-04-012025-03-3102113867core:FurnitureFittings2024-04-012025-03-3102113867core:OfficeEquipment2024-04-012025-03-3102113867core:NetGoodwill2024-04-012025-03-3102113867core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3102113867core:ListedExchangeTraded2024-04-012025-03-3102113867core:UnlistedNon-exchangeTraded2024-04-012025-03-3102113867core:MoreThanFiveYears2024-04-012025-03-3102113867core:Non-currentFinancialInstruments2025-03-3102113867core:Non-currentFinancialInstruments2024-03-3102113867dpl:CostSales2024-04-012025-03-3102113867dpl:DistributionCosts2024-04-012025-03-3102113867core:LandBuildings2024-04-012025-03-3102113867core:PlantMachinery2024-04-012025-03-3102113867core:Vehicles2024-04-012025-03-3102113867core:FurnitureFittings2024-04-012025-03-3102113867core:OfficeEquipment2024-04-012025-03-3102113867dpl:AdministrativeExpenses2024-04-012025-03-3102113867core:NetGoodwill2024-04-012025-03-3102113867core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3102113867dpl:GroupUndertakings2024-04-012025-03-3102113867dpl:ParticipatingInterests2024-04-012025-03-3102113867dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3102113867core:ListedExchangeTraded2024-04-012025-03-3102113867dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3102113867core:UnlistedNon-exchangeTraded2024-04-012025-03-3102113867dpl:CostSales2023-04-012024-03-3102113867dpl:DistributionCosts2023-04-012024-03-3102113867core:LandBuildings2023-04-012024-03-3102113867core:PlantMachinery2023-04-012024-03-3102113867core:Vehicles2023-04-012024-03-3102113867core:FurnitureFittings2023-04-012024-03-3102113867core:OfficeEquipment2023-04-012024-03-3102113867dpl:AdministrativeExpenses2023-04-012024-03-3102113867core:NetGoodwill2023-04-012024-03-3102113867core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3102113867dpl:GroupUndertakings2023-04-012024-03-3102113867dpl:ParticipatingInterests2023-04-012024-03-3102113867dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3102113867core:ListedExchangeTraded2023-04-012024-03-3102113867dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3102113867core:UnlistedNon-exchangeTraded2023-04-012024-03-3102113867core:NetGoodwill2025-03-3102113867core:IntangibleAssetsOtherThanGoodwill2025-03-3102113867core:LandBuildings2025-03-3102113867core:PlantMachinery2025-03-3102113867core:Vehicles2025-03-3102113867core:FurnitureFittings2025-03-3102113867core:OfficeEquipment2025-03-3102113867core:AfterOneYear2025-03-3102113867core:WithinOneYear2025-03-3102113867core:ListedExchangeTraded2025-03-3102113867core:UnlistedNon-exchangeTraded2025-03-3102113867core:ShareCapital2025-03-3102113867core:SharePremium2025-03-3102113867core:RevaluationReserve2025-03-3102113867core:OtherReservesSubtotal2025-03-3102113867core:RetainedEarningsAccumulatedLosses2025-03-3102113867core:NetGoodwill2024-03-3102113867core:IntangibleAssetsOtherThanGoodwill2024-03-3102113867core:LandBuildings2024-03-3102113867core:PlantMachinery2024-03-3102113867core:Vehicles2024-03-3102113867core:FurnitureFittings2024-03-3102113867core:OfficeEquipment2024-03-3102113867core:AfterOneYear2024-03-3102113867core:WithinOneYear2024-03-3102113867core:ListedExchangeTraded2024-03-3102113867core:UnlistedNon-exchangeTraded2024-03-3102113867core:ShareCapital2024-03-3102113867core:SharePremium2024-03-3102113867core:RevaluationReserve2024-03-3102113867core:OtherReservesSubtotal2024-03-3102113867core:RetainedEarningsAccumulatedLosses2024-03-3102113867core:NetGoodwill2023-03-3102113867core:IntangibleAssetsOtherThanGoodwill2023-03-3102113867core:LandBuildings2023-03-3102113867core:PlantMachinery2023-03-3102113867core:Vehicles2023-03-3102113867core:FurnitureFittings2023-03-3102113867core:OfficeEquipment2023-03-3102113867core:AfterOneYear2023-03-3102113867core:WithinOneYear2023-03-3102113867core:ListedExchangeTraded2023-03-3102113867core:UnlistedNon-exchangeTraded2023-03-3102113867core:ShareCapital2023-03-3102113867core:SharePremium2023-03-3102113867core:RevaluationReserve2023-03-3102113867core:OtherReservesSubtotal2023-03-3102113867core:RetainedEarningsAccumulatedLosses2023-03-3102113867core:AfterOneYear2024-04-012025-03-3102113867core:WithinOneYear2024-04-012025-03-3102113867core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3102113867core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3102113867core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3102113867core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3102113867core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3102113867core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3102113867core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3102113867core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3102113867core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3102113867core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3102113867core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3102113867core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3102113867core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3102113867core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3102113867core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3102113867core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3102113867core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3102113867core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3102113867core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3102113867core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3102113867core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3102113867core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3102113867core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3102113867core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3102113867core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3102113867core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3102113867core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3102113867bus:Director12024-04-012025-03-3102113867core:FurnitureFittingsToolsEquipment2024-03-3102113867core:FurnitureFittingsToolsEquipment2024-04-012025-03-3102113867core:FurnitureFittingsToolsEquipment2025-03-31

BRECKNOCK DENTAL SURGERY LIMITED

Registered Number
02113867
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

BRECKNOCK DENTAL SURGERY LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

MAROO, Neil Paresh, Dr

Registered Address

8b Accommodation Road
London
NW11 8ED

Registered Number

02113867 (England and Wales)
BRECKNOCK DENTAL SURGERY LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets4619,131545,510
619,131545,510
Current assets
Debtors1,912,8661,810,918
Cash at bank and on hand23,16931,801
1,936,0351,842,719
Creditors amounts falling due within one year5(497,033)(898,119)
Net current assets (liabilities)1,439,002944,600
Total assets less current liabilities2,058,1331,490,110
Net assets2,058,1331,490,110
Capital and reserves
Called up share capital100100
Profit and loss account2,058,0331,490,010
Shareholders' funds2,058,1331,490,110
The financial statements were approved and authorised for issue by the Director on 19 November 2025, and are signed on its behalf by:
MAROO, Neil Paresh, Dr
Director
Registered Company No. 02113867
BRECKNOCK DENTAL SURGERY LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Operating leases
Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Plant and machinery25
Fixtures and fittings25
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
2.Average number of employees

20252024
Average number of employees during the year2323
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 April 24(966,667)(966,667)
At 31 March 25(966,667)(966,667)
Amortisation and impairment
At 01 April 24(966,667)(966,667)
At 31 March 25(966,667)(966,667)
Net book value
At 31 March 25--
At 31 March 24--
4.Tangible fixed assets

Land & buildings

Plant & machinery

Vehicles

Fixtures & fittings

Total

£££££
Cost or valuation
At 01 April 2478,007424,871473,449480,7821,457,109
Additions-120,576-133,419253,995
At 31 March 2578,007545,447473,449614,2011,711,104
Depreciation and impairment
At 01 April 24-288,386230,376392,837911,599
Charge for year-64,26560,76855,341180,374
At 31 March 25-352,651291,144448,1781,091,973
Net book value
At 31 March 2578,007192,796182,305166,023619,131
At 31 March 2478,007136,485243,07387,945545,510
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables118,397681,446
Bank borrowings and overdrafts18,501300
Taxation and social security187,516-
Finance lease and HP contracts126,962180,873
Other creditors45,65735,500
Total497,033898,119